ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 186 filers reported holding ANI PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $330,187 | +17.9% | 5,687 | +9.3% | 0.00% | – |
| Q2 2023 | $280,024 | +38.7% | 5,202 | +3.6% | 0.00% | – |
| Q4 2022 | $201,914 | -27.9% | 5,019 | +10.7% | 0.00% | -100.0% |
| Q4 2019 | $280,000 | -58.0% | 4,534 | -50.4% | 0.00% | 0.0% |
| Q3 2019 | $666,000 | +132.1% | 9,141 | +161.5% | 0.00% | 0.0% |
| Q2 2019 | $287,000 | +24.2% | 3,495 | +6.6% | 0.00% | 0.0% |
| Q1 2019 | $231,000 | -1.3% | 3,280 | -6.3% | 0.00% | – |
| Q2 2018 | $234,000 | +2.2% | 3,502 | -10.9% | 0.00% | – |
| Q1 2018 | $229,000 | -9.5% | 3,931 | 0.0% | 0.00% | -100.0% |
| Q4 2017 | $253,000 | +15.0% | 3,931 | -6.2% | 0.00% | – |
| Q3 2017 | $220,000 | +1.9% | 4,192 | +17.9% | 0.00% | -100.0% |
| Q4 2016 | $216,000 | -8.5% | 3,556 | 0.0% | 0.00% | – |
| Q3 2016 | $236,000 | +6.8% | 3,556 | 0.0% | 0.00% | -100.0% |
| Q2 2015 | $221,000 | – | 3,556 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FIRST WILSHIRE SECURITIES MANAGEMENT INC | 367,754 | $10,911,000 | 4.08% |
| AIGH Capital Management LLC | 244,500 | $7,254,000 | 1.91% |
| Parkman Healthcare Partners LLC | 108,559 | $3,221,000 | 1.19% |
| Worth Venture Partners, LLC | 60,831 | $1,927,000 | 1.13% |
| Global Alpha Capital Management Ltd. | 323,731 | $9,605,000 | 1.04% |
| Mesirow Financial Investment Management, Inc. | 6,892 | $204,000 | 0.99% |
| MARATHON CAPITAL MANAGEMENT | 74,460 | $2,209,000 | 0.71% |
| EMERALD ADVISERS, LLC | 455,880 | $13,526,000 | 0.70% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 356,865 | $10,588,000 | 0.61% |
| Jackson Creek Investment Advisors LLC | 32,698 | $1,120,000 | 0.45% |